| 前收市價 | 128.80 |
| 開市 | 128.61 |
| 買盤 | 128.31 x 1000 |
| 賣出價 | 129.08 x 900 |
| 今日波幅 | 127.99 - 129.69 |
| 52 週波幅 | 99.14 - 133.10 |
| 成交量 | |
| 平均成交量 | 8,217,444 |
| 市值 | 324.886B |
| Beta 值 (5 年，每月) | 0.40 |
| 市盈率 (最近 12 個月) | 142.51 |
| 每股盈利 (最近 12 個月) | 0.90 |
| 業績公佈日 | 2024年7月30日 |
| 遠期股息及收益率 | 3.08 (2.40%) |
| 除息日 | 2024年3月14日 |
| 1 年預測目標價 | 141.42 |
BenzingaMerck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE: MRK) just reported encouraging data from its Phase III gastric cancer treatment trial after ending 2023 with good news from its combined treatment with Moderna Inc (NASDAQ: MRNA) in fighting melanoma. Merck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698 subjects, the trial evaluated the effect of a treatment that combines Merck’s immunotherapy blockb
Insider Monkey15 Best Places to Retire in Florida That You’ve Never Heard Of
This article takes a look at the 15 best places to retire in Florida that you’ve never heard of. If you wish to skip our detailed analysis of financial challenges and hidden gems in Florida, you may go to the 5 Best Places to Retire in Florida That You’ve Never Heard Of. Navigating Financial Challenges […]
Insider MonkeyMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats earnings expectations. Reported EPS is $2.07, expectations were $1.94. Merck & Co., Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank […]
